Ozempic is a prescription medication containing semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist. It is used for the management of type 2 diabetes and, in some cases, for weight management. Semaglutide, the active ingredient in Ozempic, mimics the action of GLP-1, a hormone that plays a role in regulating blood sugar levels, insulin release, and appetite. 

Indications:

Type 2 Diabetes Mellitus (T2DM):

• Ozempic is indicated for the treatment of type 2 diabetes to improve glycemic control in conjunction with diet and exercise. It can be used as monotherapy or in combination with other antidiabetic agents.

Weight Management (Obesity):

• In certain cases, Ozempic may also be used to support weight loss in patients with obesity or overweight conditions, especially when used in combination with diet and exercise.

Semaglutide, as a GLP-1 receptor agonist, stimulates insulin secretion in response to meals, suppresses glucagon release (which reduces glucose production by the liver), slows gastric emptying, and increases satiety, which can reduce appetite. Insulin Secretion & Glucose Control: It helps to control postprandial (after-meal) blood glucose levels and enhances insulin sensitivity in the body, contributing to better glucose regulation.